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An amperometric biosensor for l-glutamic acid (Glu) was
constructed by the adsorption and dip coating of
l-glutamate oxidase (GluOx, 200 U ml21 phosphate
buffer, pH 7.4) onto 60-mm radius Teflon-coated Pt wire
(1 mm exposed length). The enzyme was then trapped on
the surface by electropolymerisation of
o-phenylenediamine that also served to block electroactive
interference. This procedure afforded electrodes with
similar substrate sensitivity compared with the classical
approach of immobilising enzyme from a solution of
monomer, and represents an approximately 10 000-fold
increase in the yield of biosensors from a batch of enzyme.
A number of strategies were examined to enhance the
sensitivity and selectivity of the Pt/PPD/GluOx sensors
operating at 0.7 V versus SCE. Pre-coating the Pt with
lipid and incorporation of the protein bovine serum
albumin into the polymer matrix were found to improve
the performance of the electrode. The sensors had a fast
response time, high sensitivity to Glu, with an LOD of
about 0.3 mmol l21, and possessed selectivity
characteristics suggesting that monitoring Glu in
biological tissues in vivo may be feasible.
Keywords: Enzyme-modified electrode; polymer-modified
electrode; poly(o-phenylenediamine); ascorbic acid
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l-Glutamate (Glu) is a ubiquitous excitatory amino acid
neurotransmitter in the mammalian CNS, playing a major role
in a wide variety of brain functions.123 Glu concentrations in
brain extracellular fluid (ECF) in vivo have been estimated in
the 10 mmol l21 region using a variety of microdialysis
techniques and detection systems,428 and a number of valuable
studies on brain Glu have been reported using these method-
ologies.1,9212 The dialysis approach to monitoring brain
chemistry has certain restrictions, however, such as limited time
resolution and depletion of the ECF. As an alternative approach
to detecting species in the ECF, implantable amperometric
biosensors provide a continuous signal13 with significantly less
depletion.14
A number of sensor types have been developed for
the measurement of Glu based on a variety of metabolic
enzymes.15–20 Attention has focused mainly on the use of
l-glutamate oxidase (GluOx) that has FAD as the redox centre
and molecular oxygen as a co-substrate,21 producing hydrogen
peroxide that can be detected amperometrically19,20,22–30 or
spectroscopically.31,32 The oxidative deamination catalysed by
GluOx21 can be represented by the following steps:
l-Glutamate + H2O + GluOx/FAD ? a-ketoglutarate + NH3 +
GluOx/FADH2 (1)
GluOx/FADH2 + O2? GluOx/FAD + H2O2 (2)
The H2O2 produced (reaction 2) can be electro-oxidised and this
is generally carried out amperometrically at relatively high
applied potentials (reaction 3).
H2O2? O2 + 2H+ + 2e (3)
An important problem in the use of enzyme-modified electrodes
in biological media is interference by endogenous electroactive
reducing agents, especially ascorbic acid (AA). This problem
has been resolved, to a great extent, by the use of electro-
synthesised polymers, such as poly(o-phenylenediamine)
(PPD), that block access to the electrode surface of even
relatively small organic molecules33–39 without affecting sensi-
tivity to hydrogen peroxide,40 and a Pt/PPD/GluOx sensor has
been reported.17,24
The classical procedure for incorporating oxidase enzymes
into a protecting polymer film has been to co-deposit the
enzyme and polymer onto the electrode from a solution of the
enzyme and monomer.33–39 This is convenient and effective but
is very cost-inefficient for expensive enzymes such as GluOx.
The aim of this work was to develop a more efficient procedure
for producing Pt/ PPD/GluOx sensors with high sensitivity to
Glu. Since the intended application for these biosensors is
monitoring Glu in brain ECF, where the concentration of AA is
about 500 mmol l21,41,42 special attention was paid to blocking
interference by reducing agents.
Materials and Methods
Reagents and Solutions
The enzyme l-glutamate oxidase21 (GluOx from Streptomyces
sp.  X-119-6, EC 1.4.3.11, 200 U ml21 in 20 mmol l21
potassium phosphate buffer, pH 7.4) was obtained as a generous
gift from Yamasa Corporation, Chiba, Japan, and stored at
220 °C. The enzyme glucose oxidase (GOx) from Aspergillus
niger (EC 1.1.3.4, Type VII-S) was from Sigma Chemical Co.
(St. Louis, MO, USA). The lipid phosphatidylethanolamine
(PEA, Type II-S) and bovine serum albumin (BSA, fraction V)
were also obtained from Sigma. Stearic acid (STA), Nafion
(NAF, 1100 EW, 5% solution in alcohol) and d-glucose were
obtained from Aldrich (Milwaukee, WI, USA). All chemicals,
including o-phenylenediamine (PD, Sigma), l-glutamic acid
(Glu, Sigma), l-glutamine (Sigma) and l-ascorbic acid (AA,
Aldrich), were used as supplied.
Solutions of PD (20–400 mmol l21) were made up in 10 ml
of a phosphate-buffered saline solution (PBS) with dissolution
achieved by sonication at 25 °C for 25 min. Stock solutions of
100 mmol l21 Glu and AA were prepared in doubly distilled
water and 0.01 mol  l21 HCl, respectively, and stored at 4 °C.
All experiments were carried out in vitro in PBS (pH 7.4) that
consisted of 0.15 mol l21 NaCl (Merck, Poole, UK), 0.04
mol l21 NaH2PO4 (Merck) and 0.04 mol l21 NaOH (Merck).
Solutions were kept refrigerated when not in use.
Instrumentation and Software
Experiments were microcomputer controlled with data acquisi-
tion achieved using a Biodata Microlink interface, a low-noise,
low-damping potentiostat (Biostat II, Electrochemical and
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Medical Systems, Newbury, UK) and in-house software. The
linear and non-linear regression analyses were performed using
the graphical software package Prism (GraphPad Software, San
Diego, CA, USA). All experiments were done in a 25 ml glass
cell at 25 °C, using a standard three-electrode set-up with a
saturated calomel electrode (SCE) as the reference and a silver
wire in a glass sheath as the auxiliary electrode.
Preparation of the Working Electrodes
All the working electrodes were based on Pt cylinders (60 mm
radius) prepared by cutting strips of Teflon-coated platinum
wire, sliding the Teflon along the wire to expose about 1 mm of
metal and sealing the Teflon rim with cyanoacrylate adhesive.
The exposed metal was then dipped a number of times into 20 ml
of a buffered solution of GluOx or GOx to deposit the enzyme.
The number of dips varied (see below) but in all cases the first
dip was left in the enzyme solution for 5 min to allow adsorption
of the enzyme to occur.17,24,43,44 For all subsequent dips the
electrode was immersed in the enzyme solution, removed
immediately and allowed to dry for 5 min.
The enzyme-coated wire was introduced into PBS containing
the monomer (20–400 mmol l21 PD) and, in some cases, the
non-enzyme protein BSA (5 mg ml21),45 and electropolymer-
isation carried out immediately at 0.7 V versus SCE. The
polymerisation time for this self-sealing process was 30 min,
unless stated otherwise. In some cases the lipid PEA45,46 or fatty
acid STA was used to coat the Pt before enzyme deposition.
This procedure involved dipping the bare Pt wire a number of
times into PEA or STA dissolved in chloroform (100 mg ml21),
allowing the solvent to evaporate each time (1 min).
Calibrations were performed amperometrically at 0.7 V
versus SCE in quiescent air-saturated PBS for glucose in the
range 0–10 mmol l21 and for Glu in the ranges 0–100 mmol l21
(for LOD and linearity studies) and 0–10 mmol l21 (for Km and
Vmax determinations). Calibrations for interfering substances
were also carried out under the same conditions except N2-
saturated buffer was used: ascorbate (AA, 0–1 mmol l21),
dopamine (DA, 0–10 mmol l21), 3,4-dihydroxyphenylacetic
acid (DOPAC, 0–100 mmol l21) and uric acid (UA, 0–100 mmol
l21). Air-saturated solutions were used in the determination of
l-glutamine interference (0–1 mmol l21).
Since the resting level of AA in brain ECF has been
estimated41,42 at 500 mmol l21 and because the AA response at
PPD-modified electrodes is non-linear (decreasing with higher
concentrations),40,45 500 mmol l21 AA responses were deter-
mined by adding 500 mmol l21 AA to 500 mmol l21 AA in PBS,
corresponding to a doubling of the baseline ECF concentration
of AA. This approach to quantifying interference by AA is
further justified by the finding that doubling the concentration
of AA in the ECF in vivo had no detectable effect on the current
recorded with a Pt/PPD/GOx sensor, even several days after
implantation.39
Data Analysis
Calibration plots for Glu were generated by plotting averaged
steady-state currents versus substrate concentration and fitting
the data using non-linear regression to obtain the apparent
Michaelis-Menten constants Vmax (nA) and Km (mmol l21).
Linear regression was used for the 0–100 mmol l21 data to
determine sensitivity in the linear response region and correla-
tion coefficients.
The selectivity coefficient of each electrode type for Glu vs.










The ıIGluı and ıIAAı used here were the absolute steady-state
currents for 10 mmol l21 Glu and 500 mmol l21 AA,
respectively. The range of interest for SAA is 0–100%: 0%
corresponds to IGlu and IAA being equal; negative values reflect
interference current greater than the signal for the target
substrate; and 100% corresponds to no AA signal for an
increase in concentration of 500 mmol l21.
All data are reported as mean ± s with n being the number of
electrodes. Unpaired, two-tailed t-tests were used to compare
responses for different electrode designs. Values of  p < 0.05
were taken to indicate statistically significant differences
between groups of electrodes.
Results and Discussion
Pt/PPD/GOx Electrodes
Previous studies on the immobilisation of enzymes into the non-
conducting form of the polymer PPD have involved either
electropolymerisation from a solution of the enzyme plus
monomer33–39 or from a monomer solution using electrodes
with pre-adsorbed enzyme.17,24 The former approach uses large
amounts of enzyme, typically 5 mg ml21, whereas the latter
leads to sensors with relatively poor sensitivity for substrate.17
To develop a sensor for Glu, using the expensive enzyme
GluOx, we investigated here the use of ‘dip coating’ to deposit
enzyme on the electrode surface prior to electropolymerisation
in solution of monomer, PD.
To compare the effectiveness of the dip coating approach to
the standard co-deposition of enzyme and polymer from
solution, we used GOx as a model enzyme. Because our sensor
development programme is motivated by applications in
mammalian brain, we have used concentrations appropriate to
this environment in many of the experiments.
The average current density for 500 mmol l21 glucose,
recorded amperometrically at 0.7 V versus SCE with Pt/PPD/
GOx sensors produced by polymerisation in a 5-ml solution
containing 5 mg ml21 GOx and 300 mmol l21 PD, was 1.8 ±
0.9 mA cm22 (n = 13); this combination of enzyme and
monomer has been shown previously to be optimal for these
conditions.40 The currents for 500 mmol l21 glucose recorded
under the same conditions with sensors produced by different
numbers of dip coatings using a 200 U ml21 GOx solution (to
mimic the GluOx solution supplied) followed by polymer-
isation in 300 mmol l21 PD were: 1 dip, 0.7 ± 0.1 nA (n = 2);
2 dips, 3.8 ± 2.3 nA (n = 3); 5 dips, 5.1 ± 2.0 nA (n = 3); 10
dips, 10.9 ± 4.8 nA (n = 3); and 20 dips, 3.1 ± 1.6 nA (n = 2).
There was a maximum in the response for 10 dips that
corresponds to a current density of 2.8 ± 1.3 mA cm22 (n =
3).
Thus, the response of sensors produced by the dip coating
method was at least as good as the classical co-deposition
procedure. In addition, the reproducibility of the sensors’
sensitivity to Glu (as measured by the coefficient of variation)
was the same for the two methods of production.
Pt/PPD/GluOx Electrodes
Having established that GOx could be successfully immobilised
by dip coating followed by polymerisation, the procedure was
applied to GluOx. The amperometric responses at 0.7 V versus
SCE for 10 mmol l21 Glu, recorded with sensors produced by
different numbers of dip coatings using a 200 U ml21 GluOx
solution followed by polymerisation in 300 mmol l21 PD, were:
1 dip, 0.62 ± 0.02 nA (n = 2); 2 dips, 0.59 ± 0.14 nA (n = 2);
5 dips, 0.78 ± 0.24 (n = 5); and 10 dips, 0.66 ± 0.35 (n = 5).

































Surprisingly, and in contrast to GOx, there was no distinct peak
in the current versus number of dips. Five dips was chosen as the
standard for further experiments as this gave the largest (albeit
not statistically different) response; this sensor is represented as
Pt/PPD/GluOx. Approximately 60 sensors were made from
each 20 ml aliquot of enzyme, representing an approximately
10 000-fold increase in the efficiency of GluOx immobilisation
compared with the co-deposition method.
The sensitivity of the sensor corresponds to a current density
of 0.20 ± 0.07 mA cm22 (n = 5) for 10 mmol l21 Glu and
compares very favourably with other biosensors for Glu.16,17,20
These basic sensors exhibited Michaelis–Menten kinetics with
a Vmax of 6.2 ± 0.9 nA and a Km of 0.25 ± 0.10 mmol l21, n =
4, the latter value being the same as that observed for GluOx in
solution.21
Considering the sensitivity of Pt to AA,40 bare cylinders of
the dimensions used here would be expected to give about 400
nA for 500 mmol l21 AA. The actual response to this
concentration of AA determined using Pt/PPD/GluOx sensors
was only 0.8 ± 0.3 nA (n = 5), indicating that the PPD film is
blocking access to the Pt surface quite efficiently. This barrier,
however, is not sufficient for neurochemical applications since
the selectivity coefficient for 10 mmol l21 Glu versus 500
mmol l21 AA, SAA (see eqn. 4), was 211 ± 40% (n = 5), i.e.,
the current for AA was similar to that for Glu at these
concentrations.
Pt/PEA/PPD/GluOx Electrodes
The improved selectivity afforded by undercoating the enzyme
layer with large molecules, such as PEA,45,46 is due to the fact
that different sites are involved in the oxidation of interference
molecules (Pt surface) and the substrate (enzyme) (see Fig. 1).
Thus, PEA efficiently blocks access to the Pt surface for AA,
say, but does not hinder access of Glu to the enzyme (reaction
1). Furthermore, the sensitivity of Pt to the small H2O2 molecule
(reaction 3) is not affected by macromolecules on the metal
surface.40
Pre-coating Pt disks with the lipid PEA by drop coating from
chloroform before electropolymerisation has been shown
previously to enhance the interference blocking properties of
biosensors.45,46 Since drop coating also led to a slower response
time,45 the dip coating method was investigated here as an
alternative means of depositing PEA onto bare Pt cylinders
before immobilisation of the GluOx. The effect of 0–10 dips in
a PEA solution (100 mg ml21 in chloroform) on the response of
the sensor to 10 mmol l21 Glu and 500 mmol l21 AA was
determined.
The presence of lipid had no significant effect on the Glu
response. Increasing the amount of PEA on the surface,
however, decreased the AA response and had a maximum effect
for 5 dips (0.33 ± 0.03 nA, n = 3, p < 0.05, compared with no
PEA, 0.78 ± 0.29, n = 5). The observation that 10 dips was less
effective than 5 dips may be caused by inhibition of PPD
formation at this higher surface coverage of PEA. Although the
characteristics of the Pt/PEA/PPD/GluOx sensor were im-
proved by the PEA (SAA = 43 ± 10%, n = 3), the selectivity of
the electrode was still not considered adequate for neu-
rochemical analysis in vivo.
Pt/PEA/PPD/BSA/GluOx Electrodes
The ability of non-conducting PPD films formed at neutral pH
(about 10 nm thick34,48) to block interference appears to be
enhanced by the incorporation of protein (enzyme and non-
enzyme) into the polymer matrix;40,45 both electrochemical and
electron microscopy data suggest that PPD films are more
compact when formed by electropolymerisation in monomer
solution containing protein.40 Although enzyme is present on
the Pt for the sensors described here so far, protein was not
present in the polymerisation solution. Electropolymerisation in
solutions of PD and BSA (5 mg ml21, a concentration that has
been shown to be optimal for our conditions45) was therefore
carried out in attempts to improve the selectivity further.
The data in Table 1 show that there was indeed a significant
(p < 0.01) improvement in SAA (83 ± 9%, n = 9) when BSA
was incorporated into the PPD sensor. Surprisingly, this
improvement was due to both an increase in the Glu current and
a decrease in the AA response. Thus, the co-deposition of
protein with the polymer may protect some GluOx molecules
from inactivation by the polymerisation process in a similar way
to that in which BSA protects enzymes during cross-linking
with glutaraldehyde.49
A schematic illustration of a Pt/PEA/PPD/BSA/GluOx
electrode, based on both structural and electrochemical data, is
shown in Fig. 1. The thickness of the non-conducting PPD film
formed under neutral conditions (about 10 nm34,48) is similar to
the diameter of oxidases such as GOx39 (about 9 nm, 180 kD)
and GluOx (about 140 kD21), whereas the size of the smaller
BSA molecule (about 70 kD) is not critical. One might expect,
therefore, that the binding site of a population of GluOx
molecules would not be hindered by the polymer.33 This view is
supported by the reported rapid response times (e.g., 1 s34 or
< 10 s39,40,45) for glucose at PPD/GOx electrodes and for Glu at
PPD/GluOx sensors (see Fig. 2, below). Although PPD
efficiently blocks access to the metal for molecules the size of
AA, Glu, glucose, etc., the small H2O2 molecules produced
enzymatically (reactions 1 and 2) can diffuse to the Pt surface to
be oxidised40 (reaction 3). The PEA underlying the enzyme
layer provides additional blocking of the Pt surface for
interferences, such as AA, but does not hinder access of Glu to
the enzyme (reaction 1).
Other Modifications of the Sensor
Stearic (octadecanoic) acid (STA) has been used in the past in
attempts to block interference by AA in neurotransmitter
detection using carbon electrodes.50,51 The rationale is that the
presence of carboxylate anions on the surface (at pH 7.4) should
reject AA anions by electrostatic repulsion. We therefore
replaced the zwitterionic PEA with STA (5 dips in 100 mg ml21
chloroform) in the dip coating of the Pt prior to enzyme
Table 1 Average ± s Glu and AA currents calculated from  individual calibrations in PBS (pH 7.4) at + 0.7 V versus SCE, the  corresponding selectivity
coefficients (SAA, see eqn. 4) ± s and  LOD ± s. Number of dip coatings of each modifier was:  phosphatidylethanolamine (PEA, 100 mg ml21 in chloroform:
5),  glutamate oxidase (GluOx, 200 U ml21 phosphate buffer: 5),  stearic acid (STA, 100 mg ml21 in chloroform: 5) and Nafion  (NAF, 1% alcohol solution:
1)
Electrode design 10 mmol l21 Glu/nA 500 mmol l21 AA/nA SAA (%) LOD/mmol l21
Pt/PPD/GluOx, n = 5 0.78 ± 0.24 0.78 ± 0.29 211 ± 40 0.35 ± 0.33
Pt/PEA/PPD/GluOx, n = 3 0.61 ± 0.14 0.33 ± 0.03 43 ± 10 0.23 ± 0.33
Pt/PEA/PPD/BSA/GluOx, n = 9 1.14 ± 0.38 0.14 ± 0.12 83 ±  9 0.27 ± 0.21
Pt/STA/PPD/BSA/GluOx, n = 6 1.29 ± 0.34 0.36 ± 0.17 71 ± 10 0.15 ± 0.09
Pt/NAF/PPD/BSA/GluOx, n = 3 0.43 ± 0.46 7 ± 11 <2100 1.5 ± 1.3












































deposition and subsequent polymerisation. The data in Table 1
show that the replacement of blocking agent had the opposite
effect to that expected, decreasing the selectivity coefficient (p
< 0.05) due to a larger AA response (p < 0.02). It appears
therefore that the hydrophobic properties of these molecules are
equally, if not more, important than electrostatic factors for
blocking interference.
The perfluorinated polysulfonic acid Nafion has been used
even more widely than STA to block AA interference in
neurotransmitter detection.52 However, the replacement of PEA
in the sensor using 1 dip of a 1% solution of Nafion in alcohol
had a catastrophic effect on SAA, decreasing the Glu signal and
increasing the AA current (see Table 1). Nafion may therefore
inhibit both the deposition of GluOx on the electrode and the
formation of PPD.
As final modifications of the sensor we investigated the effect
of monomer concentration and polymerisation time. At least
four sensors were made for each monomer concentration: 20,
100, 200, 300 and 400 mmol l21 PD. The value of SAA rose
steadily from -360 ± 250% (n = 4) at 20 mmol l21 PD, -50 ±
50% (n = 4) at 100 mmol l21, 15 ± 30% (n = 4) at 200 mmol
l21 to a peak value of 83 ± 9% (n = 9) at 300 mmol l21 PD, and
declined again to 66 ± 27% (n = 4) at 400 mmol l21, a
concentration close to saturation. The SAA value was also
sensitive to polymerisation time in 300 mmol l21 PD solutions,
mainly due to a decrease in AA response for longer times: 12 ±
16% (1 min, n = 3); 210 ± 100% (5 min, n = 3); 86 ± 9% (15
min, n = 2); and 83 ± 9% (30 min, n = 9). Thus,  although the
polymerisation current associated with the formation of the self-
sealing, non-conducting PPD (about 10 nm thick34,48) falls
rapidly to low steady-state values, it appears that 15 min are
needed to minimise any small pores in the polymer matrix40 (see
Fig. 1). 
Other Characteristics of the Pt/PEA/PPD/BSA/GluOx
Sensor
The sensor type with the best average selectivity was the Pt/
PEA/PPD/BSA/GluOx electrode produced by electropolymer-
isation in 300 mmol l21 PD for 15–30 min: SAA = 84 ± 9% (n
= 11) for 10 mmol l21 Glu and 500 mmol l21 AA. For use in a
given application, however, electrodes can be chosen that have
the best characteristics. For example, half of the total sample of
11 electrodes gave SAA = 92 ± 3% (n = 5). This sensor design
(see Fig. 1) may therefore be suitable for neurochemical studies
and therefore further characterisation was carried out in vitro.
The response time to Glu was of the order of the mixing time
in the cell (about 10 s, see Fig. 2), i.e., similar to Pt/PPD/GOx
electrodes33–39 but much faster than sensors incorporating PEA
by the drop coating technique.45 The sensitivity was high in the
linear range (0–100 mmol l21 Glu, 3.8 ± 1.3 nA cm22 mmol21
l, r2 = 0.99 ± 0.01, n = 4) with a low LOD (2 3 s of baseline,
see Table 1). Glutamine, a possible source of interference with
an ECF level in  the region of 100 mmol l21,53,54 had no effect
on the sensor’s response up to 1 mmol l21 (see Fig. 2). These
properties compare favourably with those of other GluOx-based
sensors in the literature.16,17,20
Fig. 2 (inset) shows a typical response of a Pt/PEA/PPD/
BSA/ GluOx electrode to 500 mmol l21 AA. The average size of
the response was small (0.14 ± 0.12 nA; see Table 1),
representing an approximately 2500-fold decrease in sensitivity
compared with bare Pt. Taken with the slow response time
(about 2 min), the data indicate that the PEA and PPD films
offer a significant barrier to AA diffusion to the Pt surface (see
Fig. 1).
AA has been shown to interfere with biosensors by another
mechanism, i.e., a homogeneous reaction with hydrogen
peroxide that decreases the sensors’ response to substrate.39
Normally this reaction is too slow to be a problem,55,56 but it can
be catalysed by heavy metal ions57 or peroxidases.58 Thus, trace
metal impurities in the buffer can lead to negative interference
by AA in vitro, but the effect can be blocked by the
incorporation of EDTA in the buffer.39 Since AA has been
shown to decrease the response to Glu of a GluOx-based
assay,32 Glu responses were recorded in the presence and
absence of AA (500 mmol l21) plus EDTA (1 mmol l21); there
was no difference in Glu sensitivity under the two conditions
(data not shown). This mode of interference by AA is also
Fig. 1 Schematic illustration of a Pt/PEA/PPD/BSA/GluOx sensor
fabricated by: dip coating the lipid phosphatidylethanolamine (PEA)  from
a chloroform solution onto bare Pt; adsorption and dip  coating of
l-glutamate oxidase (GluOx) from an aqueous buffer onto the PEA layer;
and electrosynthesis of the non-conducting  form of polyphenylenediamine
(PPD) in a PBS solution (pH 7.4)  containing monomer and bovine serum
albumin (BSA). See text for  the rationale of the scheme. The GluOx-
catalysed oxidative deamination of l-glutamate (Glu)  yielding H2O2 is
given in the text by reactions 1 and 2. The small  H2O2 molecules can diffuse
easily to the Pt surface to be  electro-oxidised (reaction 3) with a
characteristic fast response time  (see Fig. 2). Access to the metal by larger
electroactive species,  such as ascorbic acid (AA), is severely restricted by
the PPD, PEA  and proteins, with a correspondingly small and slow
response (see  Fig. 2, inset).
Fig. 2 Example of amperometric calibration data for glutamate (Glu,
0–10 mmol l21) recorded at 0.7 V versus SCE with a Pt/PEA/PPD/BSA/
GluOx electrode (see Fig. 1), also showing the lack of sensor  response to
5 injections of +200 mmol l21 glutamine. The inset  shows an example of a
500 mmol l21 AA response (see Table 1 for  data).

































absent in brain tissue, presumably owing to the absence of
suitable catalysts.39
Table 2 shows the response to a variety of other interfering
substances found in brain ECF. Modification of the Pt with the
PEA/PPD/BSA film (Fig. 1) reduced its sensitivity to DA,
DOPAC and UA about 100 fold, and the responses were linear
in the low concentration ranges tested. At the levels of these
species found in the ECF, the corresponding current (see Table
2) would be negligible compared with the 10 mmol l21 Glu
signal ( >1 nA, see Table 1). Interference by UA is complicated
by the finding that its concentration in brain ECF depends on the
size of the electrode59 but for sensors of the size used here, UA
concentrations would be < 5 mmol l21. Thus, although the
presence of AA (and not other endogenous species, such as
DA17) is the most significant limitation for the application of
biosensors in brain tissue, the selectivity of the Pt/PEA/PPD/
BSA/GluOx electrode developed here suggests suitability for
neurochemical applications in vivo. A more complicated
combination of Nafion, ascorbate oxidase, cellulose acetate,
glutaraldehyde, BSA and GluOx has been used in one study to
produce a sensor with an equivalent SAA of about 99%;16
however, there has been a paucity of reports on applications
using this sensor in the years since its first appearance.
Conclusions
The relatively simple fabrication of a sensor for Glu, based on
the efficient use of GluOx, has been described. The sensor has
high sensitivity for substrate and sufficient selectivity to provide
a basis for neurochemical applications in vivo. Detailed
characterisation remains to be carried out in brain tissue in vivo,
however, before the sensor can be used to monitor Glu
unambiguously in the ECF.
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